Isomorphic raises $2.1B to push AI-designed drugs toward clinic
DeepMind spinout Isomorphic Labs raised $2.1 billion as Demis Hassabis now points to first AI-designed drugs entering human trials by late 2026.
Notícias e análises sobre AlphaFold
1 artigos verificados sobre AlphaFold, produtos e movimentos do setor.